Print Send My Information

Purpose

The objective of this trial is to assess the safety and effectiveness of the study device in subjects with degenerative mitral valve disease receiving a mitral valve repair without cardiopulmonary bypass (treatment group) when compared to subjects receiving mitral valve repair using standard surgical techniques with cardiopulmonary bypass (control group).

Condition

Eligibility

Eligible Ages
Over 21 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Is a candidate for mitral valve repair with cardiopulmonary bypass - Has Grade III moderate or Grade IV severe degenerative mitral valve regurgitation - Primary segmental prolapse of the A2 or P2 segment or prolapse extending to an adjacent segment (P1, P3, A1, A3) who have a single eccentric regurgitant jet on echocardiogram - Anterior leaflet covers at least 65% of anterior-posterior annular distance or an anterior leaflet that would provide sufficient coaptation after chord placement - Anatomic and general suitability

Exclusion Criteria

  • Prior mitral valve surgery - Concomitant cardiac procedures - Other cardiac procedures within 3 months

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Treatment Group 		Subjects with degenerative mitral valve insufficiency treated with artificial chordae implanted using the NeoChord DS1000
  • Device: NeoChord DS1000
    Trans-apical, beating heart repair of degenerative mitral valve insufficiency with artificial chordae implanted with the NeoChord DS1000
Active Comparator
Control Group 		Subjects with degenerative mitral valve insufficiency treated with standard surgical mitral valve repair
  • Device: Surgical Mitral Valve Repair
    Surgical repair of degenerative mitral valve insufficiency with cardiopulmonary bypass, and annuloplasty ring and some form of leaflet repair or artificial chordae.

Recruiting Locations

Sutter Health/Alta Bates Summitt Medical Center
Oakland 5378538, California 5332921 94609

Mercy General Hospital
Sacramento 5389489, California 5332921 95819

Stanford University
Stanford 5398563, California 5332921 94305

MedStar Washington Hospital Center
Washington D.C. 4140963, District of Columbia 4138106 20010

Piedmont Heart Institute
Atlanta 4180439, Georgia 4197000 30339

Franciscan Health
Indianapolis 4259418, Indiana 4921868 46237

Johns Hopkins University
Baltimore 4347778, Maryland 4361885 21287

University of Michigan
Ann Arbor 4984247, Michigan 5001836 48109

Mount Sinai, Icahn School of Medicine
New York 5128581, New York 5128638 10029

Columbia University Medical Center
New York 5128581, New York 5128638 10032

Pinnacle Health
Harrisburg 5192726, Pennsylvania 6254927 17110

University of Pittsburgh Medical Center
Pittsburgh 5206379, Pennsylvania 6254927 15232

St. Thomas
Nashville 4644585, Tennessee 4662168 37205

Baylor - Plano
Plano 4719457, Texas 4736286 75093

Valley Health System | Virginia
Winchester 4794120, Virginia 6254928 22601

More Details

NCT ID
NCT02803957
Status
Recruiting
Sponsor
NeoChord

Study Contact

David H Adams, MD
212-659-6820
david.adams@mountsinai.org

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.

For help using this page: trialstoday@researchmatch.org or call 855-514-7001

ResearchMatch is funded in part by the National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program, led by the NIH’s National Center for Advancing Translational Sciences (NCATS), grants UL1TR000445 and 1U54RR032646-01, and grant U24TR001579 from NCATS and the National Library of Medicine. The content of this website is solely the responsibility of ResearchMatch and Vanderbilt University and does not necessarily represent the official views of the NIH, NCATS, or NLM.

Vanderbilt University Medical Center